In the first half of the year, the net income of SWEI increased by more than 50%, and the growth of non-clothing trinket categories accelerated. | Interpretations of Financial Report
① In the first half of the year, Saivetime's revenue and net profit both doubled; ② On the channel side, the growth rate of emerging platforms is significant; ③ The company responded to the rise in sea freight prices by accumulating premiums and connecting to Amazon's first-mile service.
Unblinding of phase II trials led to two consecutive daily limit increases! Fujian Cosunter Pharmaceutical emphasizes uncertainty in the research and development of domestically produced "First-in-class" innovative drugs for hepatitis B. | Speed reading a
After two consecutive 20CM daily limit rises within three trading days, Fujian Cosunter Pharmaceutical quickly issued a notice to put out the fire, emphasizing that there is still uncertainty in the R&D of its first-in-class innovative drug for hepatitis B. Industry experts believe that the positive results of clinical trials and investor sentiment are the main factors affecting the market. Previously, Beigene had introduced a similar pipeline, but there was no follow-up.
Chongqing Lummy Pharmaceutical, a 'Viagra concept stock,' lost its appeal in the second trial. After several years of litigation, is the drama still not over? | Quick Read Announcement
On the evening of the 2nd, chongqing lummy pharmaceutical disclosed the results of the second trial of the litigation between its subsidiary and Haiyue pharmaceutical regarding a sales contract, and the final judgment reduced the amount of sales payment that lummy pharmaceutical needs to pay to Haiyue pharmaceutical. Chongqing lummy pharmaceutical has not yet decided whether to apply for retrial, which is expected to affect the total profit by approximately 29.69 million yuan. In 2023, the net income of chongqing lummy pharmaceutical was -55.5989 million yuan, mainly due to the litigation.
Taiwan Semiconductor's urgent orders in mainland China have surged, indicating a positive trend in the semiconductor industry's recovery.
According to industry insiders, Taiwan Semiconductor has received an increase in orders for Super Urgent (SHR) from mainland Chinese customers, and customers are willing to pay a 40% premium for this. Tianfeng Securities' Pan Jian pointed out that looking at the whole year, it is expected that the shipment volume of mobile phones/PCs will increase compared to the previous year, and the tide of terminal replacement brought by AI and the construction of cloud computing will both drive semiconductors into a new cycle.
Are the top ten tradable shareholders holding more than 100% of the total shares? Bojun Technology What is the reason for this? The company just responded
① Netizens are watching the phenomenon where the total shareholding ratio of the top ten tradable shareholders of Bojun Technology exceeds 105%; ② is it also because of financial transformation? Investors speculate a lot, what is the truth behind it? ③ Company response: No transfer was carried out due to differences in disclosure standards.
Tesla's shareholders' meeting will be held on June 13, and humanoid robots are expected to be catalyzed by events
① The 2024 Tesla Shareholders' Meeting will be held on June 13, and several Optimus clips will be shown in the promotional video. ② China Aviation Securities predicts that with the launch of Tesla Optimus, humanoid robots will enter the first year of mass production in 2025.